Update shared on 16 Dec 2025
Fair value Decreased 0.077%Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.
What's in the News
- MetLife fully completed a $3.0 billion share repurchase program announced on May 1, 2024, buying back a total of 37.6 million shares, or 5.45 percent of outstanding shares. This included 49,311 shares for $3.86 million repurchased between July 1 and July 31, 2025 (company filing).
- The company repurchased 8.18 million shares, or 1.23 percent of outstanding shares, for $647.62 million from July 1 to October 31, 2025, fully completing a separate buyback authorized on April 30, 2025 (company filing).
- MetLife and Alight announced a strategic collaboration to integrate MetLife institutional income annuities into the Alight Worklife platform. This will offer defined contribution participants access to guaranteed retirement income solutions such as MetLife Guaranteed Income fixed immediate annuities and Retirement Income Insurance QLACs (company announcement).
- MetLife and Empathy formed a strategic alliance to launch Leave Support, a digital platform that guides employees through the emotional, practical and administrative aspects of taking and returning from a leave of absence, complementing MetLife My leave Navigator (company announcement).
Valuation Changes
- The fair value estimate has edged down slightly to approximately 92.93 dollars from 93.00 dollars, reflecting a modestly more conservative valuation.
- The discount rate has risen slightly to about 7.68 percent from 7.46 percent, increasing the assumed cost of capital applied to future cash flows.
- Revenue growth has eased marginally to roughly 5.62 percent from 5.66 percent, indicating a slightly more tempered top line outlook.
- The net profit margin has improved modestly to around 7.66 percent from 7.53 percent, reflecting expectations for better underlying profitability.
- The future P/E has increased slightly to about 10.66 times from 10.35 times, suggesting a small expansion in the valuation multiple applied to forward earnings.
Have other thoughts on MetLife?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
